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Abstract
As genome-wide association studies grow in popularity for the identification of genetic factors for
common and rare diseases, analytical methods to comb through large numbers of genetic variants
efficiently to identify disease association are increasingly in demand. We have developed a pattern-
based data-mining approach to discover unlinked multilocus genetic effects for complex disease and
to detect genotype × phenotype/genotype × environment interactions. On a densely mapped
chromosome 18 data set for rheumatoid arthritis that was made available by Genetic Analysis
Workshop 15, this method detected two potential two-locus associations as well as a putative two-
locus gene × gender interaction.
Background
Long considered to hold promise for dissecting the
genetic etiology of complex diseases [1], genome-wide
association studies have produced significant and some-
times highly reproducible findings in an increasing
number of publications [2]. Despite early successes that
demonstrated the feasibility of whole-genome studies,
strategies for fully analyzing genome-wide data, such as
detecting multilocus genetic effects for complex disease or
detecting genotype × phenotype/genotype × environment
interactions, are still underdeveloped or underutilized,
affecting the effectiveness of those large-scale studies on
advancing our understanding of the genetic contribution
to common human diseases [3,4]. An increasing number
of methods have been proposed to detect multilocus
genetic association: some make use of haplotypes [5] or
logistic regression [6], while others use nonparametric
"data mining" strategies such as the multifactor dimen-
sionality reduction (MDR) [7] and neural networks [8].
Methods to analyze pair-wise interactions between
unlinked loci have also been developed [9].
We have developed a pattern-based mining strategy (man-
uscript in preparation) to detect local (markers in moder-
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ate or strong linkage disequilibrium, or LD) and global
(unlinked markers) multilocus genetic associations as
well as gene × gene/gene × environment interactions. The
pattern-based method exhaustively yet efficiently identi-
fies all patterns satisfying pre-defined pattern search crite-
ria and evaluates the association of patterns to disease
state through a χ2-based test statistics. For the work
described in this report, we applied the pattern-based
method on the chromosome 18 data set on rheumatoid
arthritis (RA) ascertained by the North American Rheuma-
toid Arthritis Consortium (NARAC) that was made avail-
able for the Genetic Analysis Workshop 15 (GAW15). Ten
patterns were found to be significantly associated with the
RA phenotype after multiple testing correction. The signif-
icance of those ten patterns was confirmed using Monte
Carlo simulation. Furthermore, we identified a poten-
tially significant multi-gene/gender interaction involving
two loci: SNP0177 and the LD region containing markers
SNP0603–SNP0615.
Methods
Pattern Examiner: a pattern-based method to detect 
multi-locus association and interaction
Data are organized in a two-dimensional data matrix with
markers as columns, individuals as rows, and individuals'
alleles or genotypes as cell values. Each marker is repre-
sented by five columns: one column for each of the two
alleles of the marker and one column for each of the three
possible genotypes for the marker. A pattern is defined as
a maximal sub-matrix of the data matrix in which the
value of each marker across all individuals in the sub-
matrix satisfies a predefined equivalence criterion such as
same genotype value. A sub-matrix is maximal if 1) no
more rows can be added while keeping the columns fixed
and, 2) no more columns can be added when keeping the
rows fixed. Under this formulation patterns can be used to
model both multilocus allelic and multilocus genotypic
contributions to disease state.
Pattern Examiner is a nonparametric data mining-based
method for the detection of multilocus associations and
gene × gene/gene × environment interactions on data col-
lected in population-based case/control studies. This
method has two steps: 1) pattern discovery and 2) signif-
icance evaluation. In the pattern discovery step, patterns
are identified using as input data from the case population
only. The extensiveness (and execution time) of the pat-
tern discovery step is controlled by two parameters: the
support threshold, which specifies the minimum number of
rows a pattern must have; and the locus threshold, which
specifies the extent of locus interaction. For example, with
the support and locus thresholds set to 20 and 2 respec-
tively, all reported patterns will have 20 or more case sup-
ports and mostly one or two markers. In the significance
evaluation step, a 2 × 2 contingency table is constructed
for each pattern to tally its support in the case and control
populations ("case support" and "control support",
respectively). The two categorical variables tabulated are
population type ("cases" vs. "controls") and pattern
match status ("matches" vs. "does not match"). Partially
missing data are excluded. The p-value is obtained from a
χ2 test of independence and then adjusted for multiple
testing. A modified Bonferroni correction for multiple
testing is applied to each pattern, using as the correction
factor the total number of patterns that contain equal or
greater case support than the target pattern under signifi-
cance evaluation, rather than the total number of patterns
identified. As a result, the adjusted significance is robust
against the arbitrary selection of values for parameters in
the pattern discovery step. The odds ratio with confidence
interval is also calculated for each pattern.
Test for differential gene × gender interactions in cases vs. 
controls
To test for the null hypothesis that there is no difference
on genotype × gender interaction between cases and con-
trols, three 2 × N contingency tables were constructed with
the observed N genotypes of a significant pattern as rows
and genders as columns. Three chi-square values, χ2
case,
χ2
control, and χ2
pooled, were then obtained for cases only,
controls only, and cases and controls pooled, respectively.
The  p-value was obtained using χ2 =  χ2
case +  χ2
control -
χ2
pooled with N - 1 degree of freedom.
Results
Significant association between two-locus patterns and RA
We identified 2.6 million patterns, mostly containing two
markers, from the NARAC chromosome 18 data set, for a
support threshold of 20 and a locus threshold of 2. From
this set, 65,689 patterns were found to have p-values ≤
0.01 before multiple testing correction. After Bonferroni
correction, ten patterns remained significant, as shown in
Table 1 (Column "Adjusted p-value"). Interestingly, all
significant patterns share the following characteristics: 1)
they all contain marker SNP0177 with allele 1, suggesting
a dominant effect for marker SNP0177; 2) they all have
odds ratio around two, suggesting a modest relative risk;
3) they all have large number of case support (more than
50% of all cases), suggesting a rather common inherit-
ance; and 4) they are all mapped to intergenic regions on
chromosome 18. Furthermore, except for markers
SNP672 and SNP0177, all other markers in those ten pat-
terns are mapped to two LD blocks as identified by the
HapBlock program [10] (markers SNP1130 and SNP
1131; markers SNP0603, SNP0604, SNP0605, SNP0606,
SNP0608, SNP0609, SNP0610, and SNP0615). Similar to
marker SNP0177, single alleles for markers 1130 and
1131 were found to contribute to the significant patterns,
suggesting a dominant effect. On the other hand, all
markers in the SNP0603–0615 LD block consistentlyBMC Proceedings 2007, 1(Suppl 1):S16 http://www.biomedcentral.com/1753-6561/1/S1/S16
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demonstrated a recessive effect with the inclusion of
homozygote genotype(s) in corresponding significant
patterns.
To further evaluate the significance of those ten patterns,
we performed a Monte Carlo simulation using 400 simu-
lated data sets generated by randomizing the case-control
assignment of the 920 individuals in the study while
maintaining the female/male ratio in both cases and con-
trols. The pattern-based method was applied to each sim-
ulated data set. On average, 2.7 million patterns were
identified from each data set, which were then subject to
test statistics and multiple testing correction. In 8 out of
400 (2%) simulated data sets we observed ten or more
patterns that had p-values less than 0.05 after multiple
testing correction (false-positive patterns). In 20 out of
400 (5%) simulated data sets we observed five or more
false-positive patterns. These results suggest that the ten
significant patterns discovered in the real data set are
unlikely to be an artifact of chance alone. Furthermore, if
we consider the fact that these ten patterns share the same
marker, SNP0177, then the significance gets even
stronger: out of the 400 simulated data sets there was only
1 case (0.25%) where sharing of a common marker was
observed in ten or more patterns.
Significant interaction between multilocus genotypes and 
gender in RA
It is known that the incidence rate of RA is higher in
females. Indeed, there is a matching 3.82:1 female/male
ratio in both the case sample and control sample of this
data set. However, as shown in Table 1 (columns "No. of
cases (F/M ratio)" and "No. of controls (F/M ratio)"),
notable differences on the female/male ratio between
cases and controls were observed for many significant pat-
terns. To investigate the genotype × gender interaction fur-
ther, we constructed 2 × N contingency tables for each
marker in the significant patterns and for each significant
pattern with observed genotypes for marker or pattern as
rows. Four variations of the contingency tables were con-
structed as detailed in the legend of Table 2. Table 2 shows
a representative pattern demonstrating significant interac-
tion between multilocus genotypes and gender. Individu-
ally, marker SNP0177 or SNP0615 was not significant in
male population (bold). However together they demon-
strated strong significance in male population that
reached the same magnitude (p = 0.00118) as in females
(p  = 0.00109) despite the much smaller sample size.
When both female and male populations were considered
together ("With gender partition"), an even stronger asso-
ciation between the pair of markers and the disease was
observed. For individuals with the 1/1–1/2 genotype for
markers SNP0177 and SNP0615, an odds ratio of 11.7
(confidence interval: 1.34–102.86) was observed in
females over males. For individuals with the 2/2–1/2 gen-
otype for markers SNP0177 and SNP0615, an odds ratio
of 7.51 (confidence interval: 1.94–28.99) was observed in
males over females. Logistic regression analysis on the
interaction between the pattern and gender also yielded a
significant p-value of 0.0021 (data not shown). Further-
more, a test for differential interaction in cases and con-
trols yielded a p-value of 0.0016, suggesting that there is
significant interaction between the SNP0177–SNP0615
pattern and gender in the affected individuals vs. unaf-
fected individuals. Similar results were obtained for all
patterns containing markers in the SNP0603–0615 LD
Table 1: Significant patterns identified with the pattern-based method
Markers in pattern No. of cases 
(F/M ratio)a
No. of controls 
(F/M ratio)
Odds ratio 
(confidence interval)
Unadjusted p-valueb Adjusted p-valuec
SNP0177 (allele 1); SNP1131 (allele 1) 260 (3.9) 178 (3.3) 2.06 (1.58–2.68) 5.04 × 10-8 0.00185
SNP0177 (allele 1); SNP0610 (genotype 2/2) 259 (3.7) 180 (3.5) 2.0 (1.54–2.61) 1.57 × 10-7 0.00601
SNP0177 (allele 1); SNP1130 (allele 2) 234 (4.3) 154 (3.6) 2.06 (1.58–2.69) 8.03 × 10-8 0.00663
SNP0177 (allele 1); SNP0615 (genotype 1/1) 259 (3.7) 182 (3.4) 1.97 (1.51–2.55) 3.08 × 10-7 0.01178
SNP0177 (allele 1); SNP0603 (genotype 1/1) 229 (3.7) 151 (4.2) 2.02 (1.55–2.65) 1.49 × 10-7 0.01396
SNP0177 (allele 1); SNP0604 (genotype 2/2); 
SNP0605 (genotype 2/2)
258 (3.8) 182 (3.4) 1.95 (1.5–2.54) 4.42 × 10-7 0.01763
SNP0177 (allele 1); SNP0609 (genotype 1/1) 234 (3.6) 158 (3.7) 1.98 (1.52–2.58) 3.41 × 10-7 0.02822
SNP0177 (allele 1); SNP0606 (genotype 2/2) 255 (3.9) 181 (3.4) 1.92 (1.48–2.49) 8.68 × 10-7 0.03879
SNP0177 (allele 1); SNP0672 (allele 2) 273 (3.5) 202 (3.5) 1.86 (1.43–2.42) 2.33 × 10-6 0.04072
SNP0177 (allele 1); SNP0608 (genotype 1/1) 233 (3.6) 158 (3.7) 1.96 (1.5–2.56) 4.91 × 10-7 0.04161
Significant patterns were ordered according to their adjusted p-values. Each pattern contains markers with either individual allele or genotype.
aThe "No. of cases" column contains the number of individuals with RA who carried the specified alleles/genotypes at the specified markers in a 
pattern. The number in parenthesis indicates the female/male ratio. Similar arrangement was made for "No. in controls".
bp-Value before the Bonferroni correction.
cp-Value obtained after the Bonferroni correction.BMC Proceedings 2007, 1(Suppl 1):S16 http://www.biomedcentral.com/1753-6561/1/S1/S16
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block (data not shown). On the other hand, no differen-
tial interaction in cases and controls was observed for the
three remaining significant patterns (data not shown).
Discussion
Several lines of evidence suggest that the significant mul-
tilocus associations we detected with Pattern Examiner on
the NARAC chromosome 18 data set provided by GAW15
might be true associations: 1) except for marker SNP0177
and SNP0672, multiple markers from the same LD region
(markers SNP1130 and 1131, markers SNP0603–0615)
were found to be in different significant patterns; 2) all
markers in the same LD region displayed consistent dom-
inant (an allele in the pattern) or recessive (a homozygote
genotype in a pattern) effect; 3) a Monte Carlo simulation
with randomized cases and controls produced a type I
error probability of 0.02 for the observed results. The sin-
gleton SNP0177 does raise a flag because it is in a strong
LD region with adjacent markers. Further investigation is
necessary to confirm the role SNP0177 plays in the asso-
ciation. The ultimate proof for true association will have
to come from replication studies. Taking advantage of our
method's ability to detect multilocus association, we per-
formed a novel multilocus gene × gender interaction anal-
ysis and detected a two-locus gene × gender interaction
that was supported by three independent assays. Detailed
analysis revealed large odds ratios for certain genotype
combinations. However, a wide confidence interval (due
to small sample size) dampens our enthusiasm. Again,
further investigation with larger sample sizes is necessary
to confirm this observation.
Several reports in the "Association – Problem 2" group of
GAW15 have identified the LD region including markers
SNP1097–1107 to be significantly associated with RA
[[11]; Zhu G, Rao S, Li X, personal communication].
Although we also found markers SNP1097–1107 to be
significant using a genotype-based single-marker χ2 test (p
= 0.0002 for most markers in this region), the significance
disappeared after Bonferroni correction with 2300 mark-
ers. After applying a less stringent Bonferroni correction
using the number of LD blocks (233 LD blocks were iden-
tified by the HapBlock program) in this 10-Mb region,
those markers resurfaced as significant. Because none of
the significant patterns identified by the pattern-based
method included markers SNP1097–1107, this locus
might act alone as a risk factor for RA.
By focusing on detecting multilocus association and inter-
actions, the pattern-based method complements the tradi-
tional single marker association test. A preliminary power
analysis (data not shown) suggested that this method has
more power than the traditional single marker-based
analysis under a couple of two-locus disease models.
Additional power analysis is needed to further validate its
utility.
Conclusion
We have identified two potential multilocus associations
(SNP0177/SNP1130–1131 and SNP0177/SNP0603–
0615) with RA as well as evidence of interaction between
gender and loci SNP0177/SNP0603–0615.
Table 2: Evidence of interaction between multiple loci and gender in cases
Marker Names Typea p-Value
SNP0177 Female only 0.006738
SNP0177 Male only 0.105399b
SNP0177 With gender partition 0.012727
SNP0177 Without gender partition 0.013569
SNP0615 Female only 0.002029
SNP0615 Male only 0.246597
SNP0615 With gender partition 0.009541
SNP0615 Without gender partition 0.004517
SNP0177–SNP0615 Female only 0.001092
SNP0177–SNP0615 Male only 0.001182
SNP0177–SNP0615 With gender partition 0.000024
SNP0177–SNP0615 Without gender partition 0.000862
aFour variations of the 2 × N contingency table were constructed for each marker in the significant patterns in Table 1 and for each significant 
pattern with the observed N genotypes as rows. Each contingency table has two columns for case and control. In "Without gender partition", 
individuals were grouped and allocated to table cells according to genotypes regardless of their gender. In "With gender partition", individuals were 
grouped together according to genotypes and gender with each combination of genotype and gender as a row. In "Males only", only males were 
grouped and allocated to table cells according to genotypes. In "Females only", only females were grouped and allocated to table cells according to 
genotypes.
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